David Mann

Chief Business Officer Singulera Therapeutics Inc

Seminars

Wednesday 24th March 2027
Advancing Treg Therapies in Transplantation Through Clinical Development & Mechanistic Understanding
9:30 am
  • Reviewing emerging clinical insights from Treg therapies in transplantation to demonstrate progress toward durable graft tolerance
  • Exploring how fundamental Treg biology research is improving understanding of Treg trafficking, persistence, and function in transplant settings
  • Determining how mechanistic and clinical findings can inform the next generation of Treg-based therapies and trial designs in transplantation
David Mann